• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
H pylori recurrence after successful eradication.幽门螺杆菌成功根除后的复发情况。
World J Gastroenterol. 2008 Mar 14;14(10):1477-8. doi: 10.3748/wjg.14.1477.
2
Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication.发达国家和发展中国家幽门螺杆菌的复发情况:根除治疗后¹³C尿素呼气试验随访的荟萃分析
Helicobacter. 2008 Feb;13(1):56-61. doi: 10.1111/j.1523-5378.2008.00571.x.
3
Helicobacter pylori recrudescence and its influencing factors.幽门螺杆菌再感染及其影响因素。
J Cell Mol Med. 2019 Dec;23(12):7919-7925. doi: 10.1111/jcmm.14682. Epub 2019 Sep 19.
4
Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco).发展中国家(摩洛哥)成功根除后幽门螺杆菌的流行及其复发情况。
Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):519-26. doi: 10.1016/j.clinre.2013.02.003. Epub 2013 Apr 6.
5
[Eradication of Helicobacter pylori in developing countries].[发展中国家幽门螺杆菌的根除]
Rev Med Chil. 1997 Aug;125(8):939-49.
6
Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection.韩国一线和二线根除治疗后幽门螺杆菌复发:复发或再感染问题
Helicobacter. 2014 Jun;19(3):202-6. doi: 10.1111/hel.12117. Epub 2014 Mar 11.
7
Reinfection versus recrudescence in Helicobacter pylori infection.幽门螺杆菌感染中的再感染与复发
Aliment Pharmacol Ther. 1997 Apr;11 Suppl 1:55-61. doi: 10.1046/j.1365-2036.11.s1.10.x.
8
Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan.在日本,根除治疗后幽门螺杆菌感染的复发是由复发还是再感染引起的?
Helicobacter. 2003 Jun;8(3):186-91. doi: 10.1046/j.1523-5378.2003.00143.x.
9
Reinfection rate following effective therapy against Helicobacter pylori infection in Japan.日本幽门螺杆菌感染有效治疗后的再感染率。
J Gastroenterol Hepatol. 2002 Jan;17(1):27-31. doi: 10.1046/j.1440-1746.2002.02666.x.
10
National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index.幽门螺杆菌的复发率与人类发展指数呈显著负相关。
Aliment Pharmacol Ther. 2013 May;37(10):963-8. doi: 10.1111/apt.12293. Epub 2013 Apr 2.

引用本文的文献

1
Oral Hygiene With Neutral Electrolyzed Water and Systemic Therapy Increases Gastric Helicobacter pylori Eradication and Reduces Recurrence.使用中性电解水进行口腔卫生护理和全身治疗可提高胃幽门螺杆菌的根除率并降低复发率。
Clin Exp Dent Res. 2024 Aug;10(4):e927. doi: 10.1002/cre2.927.
2
Prevalence of Oral Infection in an Indigenous Community in Southwest Mexico.墨西哥西南部一个原住民社区口腔感染的患病率。
Clin Exp Gastroenterol. 2023 Sep 21;16:173-180. doi: 10.2147/CEG.S424559. eCollection 2023.
3
CMTM3 protects the gastric epithelial cells from apoptosis and promotes IL-8 by stabilizing NEMO during Helicobacter pylori infection.在幽门螺杆菌感染期间,CMTM3通过稳定NEMO来保护胃上皮细胞免于凋亡并促进白细胞介素-8的产生。
Gut Pathog. 2023 Feb 13;15(1):6. doi: 10.1186/s13099-023-00533-4.
4
Gut homeostasis, injury, and healing: New therapeutic targets.肠道内稳态、损伤与修复:新的治疗靶点。
World J Gastroenterol. 2022 May 7;28(17):1725-1750. doi: 10.3748/wjg.v28.i17.1725.
5
Monitoring the Reaction of the Body State to Antibiotic Treatment against via Infrared Spectroscopy: A Case Study.通过红外光谱监测机体对抗生素治疗的反应:案例研究。
Molecules. 2021 Jun 7;26(11):3474. doi: 10.3390/molecules26113474.
6
Epidemiological Profile of Infection in Patients with Digestive Symptoms in Algeria.阿尔及利亚有消化道症状患者感染的流行病学特征。
J Epidemiol Glob Health. 2020 Dec;10(4):293-297. doi: 10.2991/jegh.k.200527.001. Epub 2020 Jun 19.
7
Dentists Are at a Higher Risk for Oral Infection.牙医面临更高的口腔感染风险。
Biomed Res Int. 2020 Jul 4;2020:3945189. doi: 10.1155/2020/3945189. eCollection 2020.
8
The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.《儿童幽门螺杆菌感染管理的 JSPGHAN 指南更新版》。
Pediatr Int. 2020 Dec;62(12):1315-1331. doi: 10.1111/ped.14388.
9
Inference from the analysis of genetic structure of Helicobacter pylori strains isolates from two paediatric patients with recurrent infection.从两名复发性感染的儿科患者分离的幽门螺杆菌菌株遗传结构分析中推断。
BMC Microbiol. 2019 Aug 8;19(1):184. doi: 10.1186/s12866-019-1554-z.
10
Effects of periodontal therapy on eradication and recurrence of Helicobacter pylori infection after successful treatment.牙周治疗对幽门螺杆菌感染成功治疗后根除及复发的影响。
J Int Med Res. 2019 Feb;47(2):875-883. doi: 10.1177/0300060518816158. Epub 2019 Jan 7.

本文引用的文献

1
Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication.发达国家和发展中国家幽门螺杆菌的复发情况:根除治疗后¹³C尿素呼气试验随访的荟萃分析
Helicobacter. 2008 Feb;13(1):56-61. doi: 10.1111/j.1523-5378.2008.00571.x.
2
Helicobacter pylori recurrence and infection rate in Israeli adults.以色列成年人幽门螺杆菌复发率和感染率
Dig Dis Sci. 2008 May;53(5):1211-4. doi: 10.1007/s10620-007-0016-x. Epub 2007 Oct 16.
3
Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives.幽门螺杆菌成功根除后的再感染:阿拉斯加原住民的一项为期2年的前瞻性研究。
Aliment Pharmacol Ther. 2006 Apr 15;23(8):1215-23. doi: 10.1111/j.1365-2036.2006.02880.x.
4
Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea.韩国采用含铋剂的二线四联疗法根除幽门螺杆菌后的长期结局
Eur J Gastroenterol Hepatol. 2006 May;18(5):515-9. doi: 10.1097/00042737-200605000-00010.
5
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.多次根除治疗后幽门螺杆菌感染的复发:1000例患者的长期随访
Aliment Pharmacol Ther. 2006 Mar 15;23(6):713-9. doi: 10.1111/j.1365-2036.2006.02827.x.
6
The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review.幽门螺杆菌感染的复发:发生率及影响因素。一项批判性综述。
Am J Gastroenterol. 2005 Sep;100(9):2083-99. doi: 10.1111/j.1572-0241.2005.50043.x.
7
Recurrence of Helicobacter pylori infection 1 year after successful treatment: prospective cohort study in the Republic of Yemen.成功治疗1年后幽门螺杆菌感染复发:也门共和国的前瞻性队列研究
Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1309-14. doi: 10.1097/00042737-200412000-00012.
8
Incidence and factors influencing on Helicobacter pylori infection recurrence.幽门螺杆菌感染复发的发生率及影响因素
Rev Esp Enferm Dig. 2004 Sep;96(9):620-3; 424-7. doi: 10.4321/s1130-01082004000900005.
9
High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection.在幽门螺杆菌高感染率人群中,幽门螺杆菌的复发率和短暂再感染率较高。
Am J Gastroenterol. 2003 Nov;98(11):2395-402. doi: 10.1111/j.1572-0241.2003.07708.x.
10
Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan.在日本,根除治疗后幽门螺杆菌感染的复发是由复发还是再感染引起的?
Helicobacter. 2003 Jun;8(3):186-91. doi: 10.1046/j.1523-5378.2003.00143.x.

幽门螺杆菌成功根除后的复发情况。

H pylori recurrence after successful eradication.

作者信息

Niv Yaron

出版信息

World J Gastroenterol. 2008 Mar 14;14(10):1477-8. doi: 10.3748/wjg.14.1477.

DOI:10.3748/wjg.14.1477
PMID:18330934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2693738/
Abstract

Recurrence of H pylori after eradication is rare in developed countries and more frequent in developing countries. Recrudescence (recolonization of the same strain within 12 mo after eradication) rather than reinfection (colonization with a new strain, more than 12 mo after eradication) is considered to be responsible for most of the cases. This observation was confirmed only in developed countries, while in developing countries a recent meta-analysis demonstrated a high rate of reinfection. The proportion of H pylori annual recurrence was 2.67% and 13.00% in developed and developing countries, respectively. Nested meta-analysis (only cases with a longer follow-up and a negative (13)CUBT a year after eradication) revealed annual recurrence rate of 1.45% [relative risk (RR), 0.54] and 12.00% (RR, 0.92) in developed and developing countries, respectively. These findings support the notion that in developed countries many cases of recurrence are due to recrudescence within the first year after eradication, with a 46% drop in the recurrence rate after the first year post eradication, while in developing countries reinfection is more pronounced, and continue at the same rate since eradication. A different approach for follow-up after H pylori eradication is probably needed in patients of developing countries, since reinfection is highly prevalent.

摘要

幽门螺杆菌根除后复发在发达国家较为罕见,而在发展中国家更为常见。复发(根除后12个月内同一菌株再次定植)而非再感染(根除12个月后新菌株定植)被认为是大多数病例的原因。这一观察结果仅在发达国家得到证实,而在发展中国家,最近的一项荟萃分析显示再感染率很高。发达国家和发展中国家幽门螺杆菌的年复发率分别为2.67%和13.00%。巢式荟萃分析(仅包括随访时间较长且根除后一年(13)C尿素呼气试验阴性的病例)显示,发达国家和发展中国家的年复发率分别为1.45%[相对风险(RR),0.54]和12.00%(RR,0.92)。这些发现支持了这样一种观点,即在发达国家,许多复发病例是由于根除后第一年内的复发,根除后第一年复发率下降46%,而在发展中国家,再感染更为明显,自根除后以来一直以相同的速率持续。由于再感染非常普遍,发展中国家的患者在幽门螺杆菌根除后可能需要采取不同的随访方法。